Adrenergic beta-Agonists

"Adrenergic beta-Agonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Drugs that selectively bind to and activate beta-adrenergic receptors.

Descriptor ID	D000318
MeSH Number(s)	D27.505.519.625.050.100.200 D27.505.696.577.050.100.200
Concept/Terms	Adrenergic beta-Agonists Adrenergic beta-Agonists Adrenergic beta Agonists beta-Agonists, Adrenergic Adrenergic beta-Receptor Agonist Adrenergic beta Receptor Agonist Agonist, Adrenergic beta-Receptor beta-Receptor Agonist, Adrenergic Adrenergic beta-Receptor Agonists Adrenergic beta Receptor Agonists Agonists, Adrenergic beta-Receptor beta-Receptor Agonists, Adrenergic beta-Adrenergic Agonist Agonist, beta-Adrenergic beta Adrenergic Agonist Receptors Agonists, Adrenergic beta beta-Adrenergic Receptor Agonist Agonist, beta-Adrenergic Receptor Receptor Agonist, beta-Adrenergic beta Adrenergic Receptor Agonist beta-Adrenergic Receptor Agonists Agonists, beta-Adrenergic Receptor beta Adrenergic Receptor Agonists Betamimetics Receptor Agonists, beta-Adrenergic Receptor Agonists, beta Adrenergic Adrenergic beta-Agonist Adrenergic beta Agonist beta-Agonist, Adrenergic beta-Adrenergic Agonists Agonists, beta-Adrenergic beta Adrenergic Agonists

Below are MeSH descriptors whose meaning is more general than "Adrenergic beta-Agonists".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Molecular Mechanisms of Pharmacological Action [D27.505.519]
Neurotransmitter Agents [D27.505.519.625]
Adrenergic Agents [D27.505.519.625.050]
Adrenergic Agonists [D27.505.519.625.050.100]
Adrenergic beta-Agonists [D27.505.519.625.050.100.200]
Physiological Effects of Drugs [D27.505.696]
Neurotransmitter Agents [D27.505.696.577]
Adrenergic Agents [D27.505.696.577.050]
Adrenergic Agonists [D27.505.696.577.050.100]
Adrenergic beta-Agonists [D27.505.696.577.050.100.200]

Below are MeSH descriptors whose meaning is related to "Adrenergic beta-Agonists".

Below are MeSH descriptors whose meaning is more specific than "Adrenergic beta-Agonists".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Adrenergic beta-Agonists" by people in this website by year, and whether "Adrenergic beta-Agonists" was a major or minor topic of these publications.

Bar chart showing 29 publications over 19 distinct years, with a maximum of 4 publications in 2002

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	1	0	1
1997	1	0	1
1998	1	0	1
1999	0	1	1
2000	0	2	2
2001	0	1	1
2002	2	2	4
2003	0	3	3
2004	0	1	1
2005	0	1	1
2007	1	0	1
2008	0	2	2
2009	0	1	1
2013	0	2	2
2014	0	1	1
2015	0	1	1
2017	1	1	2
2018	1	1	2
2020	1	0	1

Below are the most recent publications written about "Adrenergic beta-Agonists" by people in Profiles.

Tervonen T, Martinez FJ, Hanania NA, Heidenreich S, Eudicone JM, Gilbert I. Dual-combination maintenance inhaler preferences in asthma and chronic obstructive pulmonary disease: A patient-centered benefit-risk assessment. Respir Med. 2021 01; 176:106278.

View in: PubMed
Chipps BE, Bacharier LB, Murphy KR, Lang D, Farrar JR, Rank M, Oppenheimer J, Zeiger RS. The Asthma Controller Step-down Yardstick. Ann Allergy Asthma Immunol. 2019 03; 122(3):241-262.e4.

View in: PubMed
Byrd JB, Newby DE, Anderson JA, Calverley PMA, Celli BR, Cowans NJ, Crim C, Martinez FJ, Vestbo J, Yates J, Brook RD. Blood pressure, heart rate, and mortality in chronic obstructive pulmonary disease: the SUMMIT trial. Eur Heart J. 2018 09 01; 39(33):3128-3134.

View in: PubMed
Lipson DA, Barnhart F, Brealey N, Brooks J, Criner GJ, Day NC, Dransfield MT, Halpin DMG, Han MK, Jones CE, Kilbride S, Lange P, Lomas DA, Martinez FJ, Singh D, Tabberer M, Wise RA, Pascoe SJ. Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD. N Engl J Med. 2018 May 03; 378(18):1671-1680.

View in: PubMed
Winther S, Isidor MS, Basse AL, Skjoldborg N, Cheung A, Quistorff B, Hansen JB. Restricting glycolysis impairs brown adipocyte glucose and oxygen consumption. Am J Physiol Endocrinol Metab. 2018 03 01; 314(3):E214-E223.

View in: PubMed
Jean-Charles PY, Yu SM, Abraham D, Kommaddi RP, Mao L, Strachan RT, Zhang ZS, Bowles DE, Brian L, Stiber JA, Jones SN, Koch WJ, Rockman HA, Shenoy SK. Mdm2 regulates cardiac contractility by inhibiting GRK2-mediated desensitization of ?-adrenergic receptor signaling. JCI Insight. 2017 09 07; 2(17).

View in: PubMed
Basse AL, Isidor MS, Winther S, Skjoldborg NB, Murholm M, Andersen ES, Pedersen SB, Wolfrum C, Quistorff B, Hansen JB. Regulation of glycolysis in brown adipocytes by HIF-1a. Sci Rep. 2017 06 22; 7(1):4052.

View in: PubMed
Wells RE, Garb J, Fitzgerald J, Kleppel R, Rothberg MB. Factors associated with emergency department visits in asthma exacerbation. South Med J. 2015 May; 108(5):276-80.

View in: PubMed
Lindenauer PK, Shieh MS, Pekow PS, Stefan MS. Use and outcomes associated with long-acting bronchodilators among patients hospitalized for chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2014 Oct; 11(8):1186-94.

View in: PubMed
Bourke JE, Bai Y, Donovan C, Esposito JG, Tan X, Sanderson MJ. Novel small airway bronchodilator responses to rosiglitazone in mouse lung slices. Am J Respir Cell Mol Biol. 2014 Apr; 50(4):748-56.

View in: PubMed

People

Explore

Similar Concepts

Top Journals